Hitting cancer with high-intensity ultrasound, immunotherapy
Saturday, March 25, 2017 - 13:11
in Health & Medicine
In a new study, researchers have shown that combining high-intensity focused ultrasound with two immunotherapies (a PD-1 checkpoint inhibitor and TLR9 agonist) can produce excellent response rates in mouse models of epithelial cancer. They also found that, for the combination to be effective, immunotherapies must come first.